HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roberson, P.L. Articles by Ensminger, W.D. Search for Related Content PubMed PubMed Citation Articles by Roberson, P.L. Articles by Ensminger, W.D.

Three-Dimensional Tumor Dosimetry for Hepatic Yttrium-90-Microsphere Therapy

Departments of Radiation Oncology, Pathology and Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan

Correspondence: For reprints contact: Peter L. Roberson, PhD, Department of Radiation Oncology. University of Michigan Medical School, UH-B2C490, Box 0010, 1500 E. Medical Center Dr., Ann Arbor, MI 48109.

ABSTRACT

The nonuniformity of dose deposition for hepatuc ⁹⁰Y-microsphere therapy is believed to play an important role in the relative sparing of normal liver tissues. To help study this issue, three-dimensional dose calculations have been performed for the VX2 tumor model in the rabbit treated with hepatic arterial administration of ⁹⁰Y-glass microspheres (⁹⁰Y-MS). Colored, nonactivated spheres of similar size to ⁹⁰Y-MS were injected into the hepatic artery to mimic the treatment deposition of ⁹⁰Y-MS. Sample blocks of treated liver were serially sectioned (200 µm thickness), fixed and photographed showing the position of the colored microspheres. The microsphere positions were digitized into a three-dimensional treatment planning system, and three-dimensional dose calculations were performed. A 2-mm diameter liver tumor nodule receiving 15 times more microspheres than nearby normal liver resulted in tumor-to-normal-tissue (TNT) calculated dose ratios of 2.6 (average dose) and 1.9 (minimum dose). The nonuniform microsphere distribution resulted in a dose gradient over the nodule with a minimum value which was less than one half the average dose. The relative dose deposition in the vicinity of the tumor nodule does not fully reconcile the known liver tolerance dose derived from uniform irradiation with the large calculated average doses tolerated with this type of therapy.

This article has been cited by other articles:

				J. E. Dancey, F. A. Shepherd, K. Paul, K. W. Sniderman, S. Houle, J. Gabrys, A. L. Hendler, and J. E. Goin Treatment of Nonresectable Hepatocellular Carcinoma with Intrahepatic 90Y-Microspheres J. Nucl. Med., October 1, 2000; 41(10): 1673 - 1681. [Abstract] [Full Text] [PDF]